Opinion: Theranos verdict won’t stop next big fraud


Holmes’ case raises the important question of whether the testimony and result will serve as object lessons for investors confronted with cheery promises in the future. Bet your money that the answer is ‘no’. — AFP

Elizabeth Holmes, the founder and CEO of the medical device company Theranos, was convicted Jan 3 on multiple counts of defrauding investors following a four-month trial in federal court in San Jose.

Theranos, which rode a tide of positive publicity in 2013 and 2014 after introducing what it claimed was novel technology for making blood testing simpler, cheaper and more efficient, shut down in 2018 after investigations established that the claims were false. Holmes and her second-in-command, Ramesh “Sunny” Balwani, were indicted on 12 counts of fraud in 2020 one count was later dropped. Balwani’s trial is scheduled for this year.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

To rival SpaceX’s Starship, ULA eyes Vulcan rocket upgrade
UnitedHealthcare CEO murder: How Silicon Valley protects its tech CEOs
AI with reasoning power will be less predictable, Ilya Sutskever says
How can I get Apple Intelligence on my device?
Google announces Android XR operating system for headsets and glasses
MicroStrategy secures Nasdaq-100 inclusion after bitcoin-fueled stock surge
Meta urges California attorney general to stop OpenAI from becoming for-profit, WSJ reports
Over 50 sex offenders in London arrested using facial recognition technology
Apple CEO Tim Cook to meet with Trump on Friday
US court rejects Tiktok request to temporarily halt pending US ban

Others Also Read